Bullfrog AI Holdings (BFRG): שווי פעילות לרווח לפני ריבית, מסים ופחת

Bullfrog AI Holdings (BFRG) is transforming drug discovery by utilizing predictive molecular modeling to optimize R&D costs. The business model relies on an asset-light profile without physical laboratories, although software implementation is currently in its initial phase. This price chart demonstrates an EV/EBITDA of 0.00, which is relevant for the bfLEAP system that enables the revival of failed tests through precise patient group selection.

The EV/EBITDA multiple determines the business value relative to its operating profit before depreciation, taxes, and interest, allowing for an assessment of the real asset value while accounting for debt load. For Bullfrog AI (BFRG), restricted access to global medical data is slowing development rates; therefore, analyzing the business's EV/EBITDA multiple helps determine an entry point with a horizon of one year or more, avoiding overpayment during local peaks.